Log in

UMED Unite de Fabrication de Medicaments BVMT · Tunisia

Unite de Fabrication de Medicaments (UMED) news

Unite de Fabrication de Medicaments is a public biotech or pharmaceutical company listed on BVMT under the ticker UMED, recorded under Tunisia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Unite de Fabrication de Medicaments news

We have not published a story on Unite de Fabrication de Medicaments yet. When there is news, it will appear here.

Questions about Unite de Fabrication de Medicaments

What is the ticker symbol of Unite de Fabrication de Medicaments?

Unite de Fabrication de Medicaments trades under the ticker UMED on BVMT.

Where is Unite de Fabrication de Medicaments listed?

Unite de Fabrication de Medicaments is listed on BVMT.

Which country or territory is Unite de Fabrication de Medicaments listed under?

Our directory records Unite de Fabrication de Medicaments under Tunisia.

What does Unite de Fabrication de Medicaments do?

Our directory classifies Unite de Fabrication de Medicaments as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Unite de Fabrication de Medicaments?

The ISIN recorded for Unite de Fabrication de Medicaments is TN0007720014.

Does aibio.space cover Unite de Fabrication de Medicaments?

aibio.space lists Unite de Fabrication de Medicaments among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Unite de Fabrication de Medicaments?

Companies in our directory listed in the same country and business area as Unite de Fabrication de Medicaments: Societe des Industries Pharmaceutiques de Tunisie SA.

Investor discussion: Unite de Fabrication de Medicaments

Members talk about Unite de Fabrication de Medicaments (UMED). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Unite de Fabrication de Medicaments is a public biotech or pharmaceutical company listed on BVMT under the ticker UMED, recorded under Tunisia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Unite de Fabrication de Medicaments
Ticker
UMED
Listing
BVMT
Country or territory
Tunisia
Business scope
Pharmaceuticals: Major
ISIN
TN0007720014
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.